Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.
Charmacy Pharmaceutical Co., Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 22, 2025, in Guangzhou City, China. The meeting will address several key resolutions, including the approval of the 2024 financial reports, amendments to meeting procedures, profit distribution plans, director remuneration, and the re-appointment of auditors. Additionally, the company plans to apply for a comprehensive revolving credit line of up to RMB 2.8 billion, which could significantly impact its financial flexibility and operational strategy.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in China, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, focusing on the Chinese market.
YTD Price Performance: -20.92%
Average Trading Volume: 2,000
Technical Sentiment Signal: Buy
Current Market Cap: HK$837M
For an in-depth examination of 2289 stock, go to TipRanks’ Stock Analysis page.